Femasys (NASDAQ: FEMY) — Perfil da empresa, notícias e dados financeiros
Femasys develops innovative women's healthcare solutions, focusing on reproductive health with less invasive and accessible treatments.
Femasys
Femasys (NASDAQ:FEMY) is a biotechnology firm focused on developing innovative solutions for women's healthcare, particularly in areas of reproductive health. The company is committed to advancing a portfolio of products and technologies aimed at filling significant gaps in women's health, particularly in fertility and contraceptive solutions. Femasys is dedicated to improving the availability and efficacy of treatments and diagnostics for women globally, with ongoing projects that include non-surgical, in-office procedures for infertility and permanent birth control. The primary objective of Femasys is to transform women's healthcare by offering less invasive, more accessible, and patient-friendly medical options, empowering women to take control of their health decisions.
Resumo
Operações
Produtos e/ou serviços de Femasys
- "FemBloc permanent birth control, a non-surgical, in-office solution providing women a permanent birth control option without hormones or invasive surgery."
- "FemaSeed localized directional insemination, a revolutionary assisted reproductive technology aimed at enhancing the success rates of conception in a simpler, less invasive manner."
- "FemCerv endocervical tissue sampler, a device designed for the collection of tissue samples from the cervical canal, improving the accuracy and efficiency of cervical health assessments."
- "FemEMB endometrial tissue sampler, a product aimed at simplifying the process of obtaining endometrial tissue samples for diagnostic purposes, ensuring minimal discomfort and increased patient compliance."
- "FemCheck, an early-stage development project for at-home diagnostics, focusing on female reproductive health to enhance accessibility and convenience for women monitoring their fertility and reproductive health."
equipe executiva do Femasys
- Kathy Lee-SepsickFounder, President, CEO & Director
- Dov ElefantChief Financial Officer
- John CanningChief Operating Officer
- Jeremy Alexander SiposChief Technology Officer
- James H. LiuChief Medical Officer
- Jeffrey Gerald MifekChief Clinical & Regulatory Affairs Officer
Últimas notícias sobre a Femasys
Principais indicadores financeiros
Resultados divulgados pela Femasys, em USD.
- Cap. de mercado
- 11,8 mi
- Receita (TTM)
- 2,3 mi
- P/L
- —
- LPA (diluído, TTM)
- -3.3
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,3 mi | -17,6 mi | -18,6 mi | |
| 1,6 mi | -17,8 mi | -18,8 mi | |
| 1,1 mi | -14,5 mi | -14,2 mi | |
| 1,2 mi | -11,6 mi | -11,4 mi |